Pradefovir Treatment for the Patients With Chronic Hepatitis B Virus Infections: a Phase3 Study

NCT04543565 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

900

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis b

Interventions

DRUG: Pradefovir Mesylate;Placebo of Tenofovir disoproxil fumarate tablet
DRUG: Tenofovir disoproxil fumarate tablet;Placebo of Pradefovir Mesylate

Sponsor

Xi'an Xintong Pharmaceutical Research Co.,Ltd.